Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
122.83
-0.60 (-0.49%)
Aug 22, 2025, 4:00 PM - Market closed
Encompass Health Stock Forecast
Stock Price Forecast
The 6 analysts that cover Encompass Health stock have a consensus rating of "Strong Buy" and an average price target of $132.83, which forecasts a 8.14% increase in the stock price over the next year. The lowest target is $122 and the highest is $140.
Price Target: $132.83 (+8.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 4 | 5 | 6 | 6 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 7 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $135 → $140 | Strong Buy | Maintains | $135 → $140 | +13.98% | Aug 14, 2025 |
| UBS | UBS | Strong Buy Maintains $130 → $140 | Strong Buy | Maintains | $130 → $140 | +13.98% | Aug 6, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $135 | Buy | Reiterates | $135 | +9.91% | Jun 5, 2025 |
| Keybanc | Keybanc | Buy Maintains $122 → $135 | Buy | Maintains | $122 → $135 | +9.91% | May 27, 2025 |
| UBS | UBS | Strong Buy Maintains $117 → $130 | Strong Buy | Maintains | $117 → $130 | +5.84% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
5.95B
from 5.37B
Increased by 10.75%
Revenue Next Year
6.46B
from 5.95B
Increased by 8.59%
EPS This Year
5.06
from 4.46
Increased by 13.42%
EPS Next Year
5.64
from 5.06
Increased by 11.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.2B | 6.8B | 7.3B | |
| Avg | 6.0B | 6.5B | 7.0B | |
| Low | 5.7B | 6.2B | 6.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 15.7% | 13.5% | 13.3% | |
| Avg | 10.8% | 8.6% | 7.7% | |
| Low | 6.9% | 4.5% | 3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 5.33 | 6.34 | 6.99 | |
| Avg | 5.06 | 5.64 | 6.17 | |
| Low | 4.83 | 5.24 | 5.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 19.6% | 25.4% | 24.0% | |
| Avg | 13.4% | 11.5% | 9.4% | |
| Low | 8.4% | 3.7% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.